BioSig Technologies, Inc. STEX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.49M+7,005% | $1.47M+4,797% | $1.49M+4,700% | $554K+1,031% | $21K-73.1% | ||
| -$3.06M-6,339% | $49K-92.2% | $49K-92.2% | $49K-92.2% | $49K-92.2% | ||
| $2.94M— | —— | —— | —— | —— | ||
| -$46.69M-1,560% | -$424.01M-38,481% | -$15.58M-714% | -$20.37M-420% | -$2.81M+17.3% | ||
| -$0.27-92.9% | -$8.23-27,333% | -$0.47-292% | -$0.74-147% | -$0.14+61.1% | ||
| 174.6M+740% | 48M+242% | 33.4M+106% | 27.7M+115% | 20.8M+111% | ||
| 174.6M+740% | 48M+242% | 33.4M+106% | 27.7M+115% | 20.8M+111% | ||
| -$497K+71.7% | -$1.75M— | -$1.75M— | -$1.75M— | -$1.75M— | ||
| —— | —— | —— | —— | $199K— | ||
| —— | $2.01M— | $2.01M— | $2.01M— | $2.01M— | ||
| $25.37M+1,123% | $48.82M— | $842K-44.5% | $5.37M+21.2% | $2.07M+95.5% | ||
| -$48.61M-1,629% | -$422.41M-38,336% | -$17.91M-836% | -$18.83M-381% | -$2.81M+17.3% | ||
| $2.94M— | —— | —— | —— | —— | ||
| -$11K— | —— | —— | —— | —— | ||
| —— | $0+100% | -$15K+89.1% | -$45K+47.7% | -$42K+50.0% | ||
| $1.93M+2,663% | —— | $1.99M+3,998% | —— | $70K— | ||
| $403K— | —— | —— | —— | —— | ||
| -$1.64M-135% | $36.78M+3,677,900% | $13.4M— | $0-100% | $4.7M+205% | ||
| -$1.5M— | -$24.47M— | —— | —— | —— | ||
| -$10.18M-813% | -$3.02M-537% | -$5.02M-237% | -$1.28M+13.7% | -$1.12M+15.1% | ||
| —— | $0-100% | $14K-88.3% | $41K-47.4% | $41K-46.8% | ||
| $37.18K-95.5% | —— | —— | —— | $818K-21.3% | ||
| $25K— | —— | —— | —— | —— | ||
| -$119K— | —— | —— | —— | —— | ||
| -$34.25M-1,056% | -$40.16M-3,383% | -$4.63M-58.4% | -$19.81M-278% | -$2.96M+11.8% | ||
| -$35.75M-1,098% | -$41.63M-3,419% | -$6.11M-107% | -$20.37M-285% | -$2.98M+13.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
